| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: TECFIDERA (dimethyl fumarate, BG-12, Fumaderm) | |
| ***************************************************** | |
| #Post#: 4220-------------------------------------------------- | |
| (Abst.) Discontinuation of dimethyl fumarate in MS --a nationwid | |
| e study [Denmark] | |
| By: agate Date: November 15, 2023, 1:45 am | |
| --------------------------------------------------------- | |
| From PubMed (November 14, 2023)--"Discontinuation of dimethyl | |
| fumarate in multiple sclerosis--a nationwide study": | |
| https://pubmed.ncbi.nlm.nih.gov/37956521/ | |
| The authors conclude that | |
| [quote]In this population-based study, we found major | |
| differences between the MS clinics in rates and reason for | |
| discontinuation of DMF. Our results suggest that management | |
| strategies during DMF treatment can reduce discontinuation | |
| rates.[/quote] | |
| Of the experimental subjects, 54.5% stopped taking Tecfidera | |
| because of adverse events, and 26.1% stopped taking it because | |
| of "active disease." It looks as if Tecfidera hasn't gone over | |
| very well, all in all. And the solution to this, the authors | |
| suggest, might be better "management strategies." | |
| The MS clinics are probably being told, in effect, that they | |
| need to manage their patients on Tecfidera better. I wonder what | |
| this means though. | |
| When I've been taking an MS drug (Avonex, Copaxone, Glatopa), | |
| the prescribing neurologist just prescribed it and ordered some | |
| standard lab work and had very little to say otherwise on the | |
| topic. When I wanted to stop the Avonex and later the Copaxone, | |
| there was no attempt at persuading me to continue. Would these | |
| better management strategies mean that patients wanting to stop | |
| an MS drug (like Tecifidera) will be more actively encouraged to | |
| stay on it? | |
| ***************************************************** |